title: Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass.
abstract: Familial hypercholesterolemia is the result of mutations in the gene that encodes the synthesis of the cellular receptor for low density lipoprotein (LDL). In the homozygous form of the disease (HFHC), cellular LDL receptors either do not form, or, when present, cannot bond LDL and mediate its cellular uptake LDL, and the cholesterol that it transports accumulate in plasma, producing severe premature atherosclerosis and death from coronary artery disease usually before the age of 20. Currently, the only effective treatment is liver transplantation, which, alone or in association with medications, normalizes plasma cholesterol levels. The authors report the cases of 2 siblings with HFHC who underwent portocaval shunt at the ages of 2.5 and 1.5 years, respectively. Portocaval shunt produced an immediate, but insufficient decrease in cholesterol (by 40% and 35%, respectively), leaving them with cholesterol concentrations of about 500 mg/dL. One year later they each underwent ileal bypass without obtaining any significant response. Liver transplantation at the ages of 18 and 16 years, respectively, reduced plasma cholesterol concentrations to 129 and 225 mg/dL, respectively. The earlier operations seriously increased the technical difficulty of liver transplantation and did not produce a favorable effect on the natural course of the disease, so portocaval shunt and ileal bypass are not indicated in HFHC, not even for the purpose of delaying liver transplantation.
authors.affiliation: Department of Pediatric Surgery, Pediatric Hospital La Paz, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: López-Santamaria
authors.forename: L
authors.initials: L
authors.lastname: Migliazza
authors.forename: M
authors.initials: M
authors.lastname: Gamez
authors.forename: J
authors.initials: J
authors.lastname: Murcia
authors.forename: M
authors.initials: M
authors.lastname: Diaz-Gonzalez
authors.forename: C
authors.initials: C
authors.lastname: Camarena
authors.forename: L
authors.initials: L
authors.lastname: Hierro
authors.forename: A
authors.initials: A
authors.lastname: De la Vega
authors.forename: E
authors.initials: E
authors.lastname: Frauca
authors.forename: M
authors.initials: M
authors.lastname: Diaz
authors.forename: P
authors.initials: P
authors.lastname: Jara
authors.forename: J
authors.initials: J
authors.lastname: Tovar
mesh_terms: D000293:Adolescent; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000235:genetics / Q000601:surgery*; D007581:Jejunoileal Bypass; D016031:Liver Transplantation / Q000379:methods; D008297:Male; D011167:Portacaval Shunt, Surgical
chemical_list: D008078:Cholesterol, LDL